Due to the large patient base in this region, the market for psoriasis treatments is anticipated to grow rapidly in North America. Additional factors driving the growth of the psoriasis treatment market include improved medical facilities, the commercialization of new diagnostic technology, medical policies, and favourable reimbursement policies. Around 3% of people worldwide have psoriasis in some form, according to the International Federation of Psoriasis Associations (IFPA).
A study that was published in the Cleveland Clinic in September 2013 estimates that there are roughly 150,000 new cases of psoriasis reported in the United States each year. A study that was published in the Medical Journal of Malaysia states that the prevalence of psoriasis in 2015 ranged from 2.0% to 3.0% globally. Africans and Japanese have the lowest incidence rates, while Caucasians have the highest rate.